Phibro Animal Health (PAHC) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Phibro Animal Health Revenue Highlights

Latest Revenue (Y)

$977.89M

Latest Revenue (Q)

$309.26M

Main Segment (Y)

Vaccines

Main Geography (Y)

UNITED STATES

Phibro Animal Health Revenue by Period

Phibro Animal Health Revenue by Year

Date	Revenue	Change
2023-06-30	$977.89M	3.78%
2022-06-30	$942.30M	13.07%
2021-06-30	$833.40M	4.12%
2020-06-30	$800.40M	-3.33%
2019-06-30	$828.00M	0.98%
2018-06-30	$820.00M	7.29%
2017-06-30	$764.30M	1.70%
2016-06-30	$751.50M	0.39%
2015-06-30	$748.59M	8.19%
2014-06-30	$691.90M	5.93%
2013-06-30	$653.15M	-0.15%
2012-06-30	$654.10M	5.78%
2011-06-30	$618.33M	4.06%
2010-06-30	$594.20M	10.63%
2009-06-30	$537.10M	5.03%
2008-06-30	$511.40M	12.89%
2007-06-30	$453.00M	13.70%
2006-06-30	$398.40M	9.33%
2005-06-30	$364.40M	2.82%
2004-06-30	$354.40M	4.91%
2003-06-30	$337.80M	2.77%
2002-06-30	$328.70M	2.82%
2001-06-30	$319.70M	-1.02%
2000-06-30	$323.00M	-

Phibro Animal Health generated $977.89M in revenue during NA 2023, up 3.78% compared to the previous quarter, and up 119.25% compared to the same period a year ago.

Phibro Animal Health Revenue by Quarter

Date	Revenue	Change
2024-12-31	$309.26M	18.75%
2024-09-30	$260.43M	-4.66%
2024-06-30	$273.16M	3.78%
2024-03-31	$263.22M	5.31%
2023-12-31	$249.94M	8.06%
2023-09-30	$231.30M	-9.31%
2023-06-30	$255.05M	3.81%
2023-03-31	$245.70M	0.43%
2022-12-31	$244.65M	5.21%
2022-09-30	$232.52M	-8.92%
2022-06-30	$255.30M	6.54%
2022-03-31	$239.62M	2.97%
2021-12-31	$232.71M	8.41%
2021-09-30	$214.66M	-2.56%
2021-06-30	$220.30M	4.05%
2021-03-31	$211.73M	2.71%
2020-12-31	$206.15M	5.61%
2020-09-30	$195.19M	5.00%
2020-06-30	$185.90M	-11.79%
2020-03-31	$210.74M	-1.53%
2019-12-31	$214.01M	12.80%
2019-09-30	$189.72M	-6.95%
2019-06-30	$203.90M	-0.89%
2019-03-31	$205.74M	-5.72%
2018-12-31	$218.22M	9.03%
2018-09-30	$200.15M	-5.50%
2018-06-30	$211.80M	1.38%
2018-03-31	$208.91M	1.47%
2017-12-31	$205.88M	6.44%
2017-09-30	$193.41M	-0.71%
2017-06-30	$194.80M	2.60%
2017-03-31	$189.86M	-0.91%
2016-12-31	$191.60M	1.92%
2016-09-30	$187.99M	-0.64%
2016-06-30	$189.20M	3.13%
2016-03-31	$183.46M	-4.33%
2015-12-31	$191.77M	2.49%
2015-09-30	$187.12M	1.17%
2015-06-30	$184.95M	-1.36%
2015-03-31	$187.50M	-0.63%
2014-12-31	$188.69M	0.66%
2014-09-30	$187.46M	2.06%
2014-06-30	$183.68M	6.01%
2014-03-31	$173.27M	0.30%
2013-12-31	$172.74M	6.48%
2013-09-30	$162.23M	-1.20%
2013-06-30	$164.20M	0.93%
2013-03-31	$162.69M	-0.90%
2012-12-31	$164.16M	1.27%
2012-09-30	$162.10M	6.79%
2009-12-31	$151.80M	11.37%
2009-09-30	$136.30M	-2.01%
2009-06-30	$139.10M	7.83%
2009-03-31	$129.00M	1.02%
2008-12-31	$127.70M	-6.24%
2008-09-30	$136.20M	-4.95%
2008-06-30	$143.30M	8.23%
2008-03-31	$132.40M	7.47%
2007-12-31	$123.20M	9.41%
2007-09-30	$112.60M	-8.31%
2007-06-30	$122.80M	13.28%
2007-03-31	$108.40M	-7.35%
2006-12-31	$117.00M	11.64%
2006-09-30	$104.80M	-0.38%
2006-06-30	$105.20M	4.26%
2006-03-31	$100.90M	1.20%
2005-12-31	$99.70M	7.67%
2005-09-30	$92.60M	-

Phibro Animal Health generated $309.26M in revenue during Q2 2025, up 18.75% compared to the previous quarter, and up 133.71% compared to the same period a year ago.

Phibro Animal Health Revenue Breakdown

Phibro Animal Health Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Vaccines	$120.85M	$100.00M	$88.32M	-	-
Animal Health	-	-	-	$72.94M	$75.34M
Mineral Nutrition	-	-	-	$220.56M	$214.41M
Performance Products	-	-	-	$67.07M	$59.04M

Phibro Animal Health's latest annual revenue breakdown by segment (product or service), as of Jun 24: Vaccines (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Vaccines	$33.17M	$32.03M	$31.99M	$32.92M	$29.73M	$26.22M	$26.20M	$22.77M	$23.02M	-	-	-	-	-	-	-	-	-	-	-
Animal Health	-	-	-	-	-	-	$176.75M	$164.43M	$163.80M	$154.86M	$22.86M	$21.87M	$21.25M	$18.73M	$18.87M	$18.27M	$17.07M	$18.62M	$21.67M	$18.67M
Performance Products	-	-	-	-	-	-	$19.85M	$18.32M	$19.20M	$18.02M	$22.00M	$15.13M	$19.23M	$16.74M	$19.20M	$15.75M	$15.38M	$13.61M	$15.56M	$14.64M
Mineral Nutrition	-	-	-	-	-	-	$58.44M	$62.92M	$61.64M	$59.65M	$69.03M	$66.66M	$54.43M	$56.81M	$58.15M	$54.16M	$51.44M	$49.88M	$56.20M	$55.69M

Phibro Animal Health's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Vaccines (100.00%).

Phibro Animal Health Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Asia Pacific	$63.23M	$61.45M	$66.93M	$58.01M	$57.30M
EMEA	$121.98M	$117.81M	$122.48M	-	-
Latin America and Canada	$247.71M	$219.85M	$191.05M	-	-
UNITED STATES	$584.76M	$578.77M	$561.80M	-	-
Vaccines	-	-	$88.32M	-	-
U	-	-	-	$494.89M	$471.94M
Europe Middle East And Africa	-	-	-	$114.13M	$112.18M
Latin America And Canada	-	-	-	$166.32M	$158.94M

Phibro Animal Health's latest annual revenue breakdown by geography, as of Jun 24: UNITED STATES (57.46%), Latin America and Canada (24.34%), EMEA (11.99%), and Asia Pacific (6.21%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Latin America and Canada	$72.67M	$71.15M	$70.17M	$53.65M	$65.18M	$58.70M	$59.90M	$53.88M	$53.82M	$52.25M	$45.05M	$48.01M	$42.66M	-	-	-	-	-	-	-
UNITED STATES	$184.44M	$143.55M	$153.68M	$159.31M	$140.48M	$131.29M	$145.05M	$148.53M	$149.39M	$135.80M	-	-	-	-	-	-	-	-	-	-
EMEA	$32.59M	$31.13M	$32.41M	$33.17M	$29.52M	$26.88M	$32.30M	$28.17M	$27.83M	$29.52M	-	-	-	-	-	-	-	-	-	-
Asia Pacific	$19.56M	$14.61M	$16.91M	$17.08M	$14.76M	$14.48M	$17.80M	$15.09M	$13.61M	$14.95M	$17.82M	$15.53M	$14.75M	$16.15M	$17.17M	$12.89M	$11.79M	$14.10M	$11.67M	$20.73M
Performance Products	-	-	-	-	-	-	-	$18.32M	-	-	-	-	-	-	-	-	-	-	-	-
Vaccines	-	-	-	-	-	-	-	$26.20M	-	-	-	-	-	-	-	-	-	-	-	-
Mineral Nutrition	-	-	-	-	-	-	-	$62.92M	-	-	-	-	-	-	-	-	-	-	-	-
Animal Health	-	-	-	-	-	-	-	$164.43M	-	-	-	-	-	-	-	-	-	-	-	-
United States	-	-	-	-	-	-	-	-	-	-	$146.82M	$139.15M	$126.32M	-	-	-	-	-	-	-
Europe, Middle East and Africa	-	-	-	-	-	-	-	-	-	-	$29.93M	$30.03M	$30.93M	-	-	-	-	-	-	-
Europe Middle East And Africa	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.17M	$27.80M	$30.29M	$26.87M	$28.87M	$31.96M	$27.66M
Latin America And Canada	-	-	-	-	-	-	-	-	-	-	-	-	-	$50.52M	$37.39M	$40.66M	$37.76M	$39.21M	$40.28M	$42.70M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	$124.44M	$129.37M	$122.31M	$118.77M	$103.71M	$126.83M	$122.92M

Phibro Animal Health's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (59.64%), Latin America and Canada (23.50%), EMEA (10.54%), and Asia Pacific (6.32%).

Phibro Animal Health Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RDY	Dr. Reddy's Laboratories	$279.16B	-
PBH	Prestige Consumer Healthcare	$1.13B	$290.32M
PAHC	Phibro Animal Health	$977.89M	$309.26M
PCRX	Pacira BioSciences	$700.97M	$168.57M
COLL	Collegium Pharmaceutical	$631.45M	$159.30M
ANIP	ANI Pharmaceuticals	$614.38M	$148.33M
PROC	Procaps Group	$409.92M	$118.41M

PAHC Revenue FAQ

What is Phibro Animal Health’s yearly revenue?

Phibro Animal Health's yearly revenue for 2023 was $977.89M, representing an increase of 3.78% compared to 2022. The company's yearly revenue for 2022 was $942.3M, representing an increase of 13.07% compared to 2021. PAHC's yearly revenue for 2021 was $833.4M, representing an increase of 4.12% compared to 2020.

What is Phibro Animal Health’s quarterly revenue?

Phibro Animal Health's quarterly revenue for Q2 2025 was $309.26M, a 18.75% increase from the previous quarter (Q1 2025), and a 23.73% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $260.43M, a -4.66% decrease from the previous quarter (Q4 2024), and a 12.59% increase year-over-year (Q1 2024). PAHC's quarterly revenue for Q4 2024 was $273.16M, a 3.78% increase from the previous quarter (Q3 2024), and a 7.10% increase year-over-year (Q4 2023).

What is Phibro Animal Health’s revenue growth rate?

Phibro Animal Health's revenue growth rate for the last 3 years (2021-2023) was 17.34%, and for the last 5 years (2019-2023) was 18.10%.

What are Phibro Animal Health’s revenue streams?

Phibro Animal Health's revenue streams in n 24 are Vaccines

What is Phibro Animal Health’s main source of revenue?

For the fiscal year ending Jun 24, the largest source of revenue of Phibro Animal Health was Vaccines. This segment made a revenue of $120.85M, representing 100.00% of the company's total revenue.